These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 34352044)

  • 41. Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.
    Fuentes-Pananá EM; Peng R; Brewer G; Tan J; Ling PD
    J Virol; 2000 Sep; 74(17):8166-75. PubMed ID: 10933728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes.
    Zimber-Strobl U; Strobl LJ
    Semin Cancer Biol; 2001 Dec; 11(6):423-34. PubMed ID: 11669604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
    Bazot Q; Paschos K; Allday MJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.
    Strobl LJ; Höfelmayr H; Marschall G; Brielmeier M; Bornkamm GW; Zimber-Strobl U
    J Virol; 2000 Feb; 74(4):1727-35. PubMed ID: 10644343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter.
    Deffrennes V; Vedrenne J; Stolzenberg MC; Piskurich J; Barbieri G; Ting JP; Charron D; Alcaïde-Loridan C
    J Immunol; 2001 Jul; 167(1):98-106. PubMed ID: 11418637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
    Gross H; Hennard C; Masouris I; Cassel C; Barth S; Stober-Grässer U; Mamiani A; Moritz B; Ostareck D; Ostareck-Lederer A; Neuenkirchen N; Fischer U; Deng W; Leonhardt H; Noessner E; Kremmer E; Grässer FA
    PLoS One; 2012; 7(8):e42106. PubMed ID: 22879910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2.
    Portal D; Zhou H; Zhao B; Kharchenko PV; Lowry E; Wong L; Quackenbush J; Holloway D; Jiang S; Lu Y; Kieff E
    Proc Natl Acad Sci U S A; 2013 Nov; 110(46):18537-42. PubMed ID: 24167291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural and functional characterization of a complex between the acidic transactivation domain of EBNA2 and the Tfb1/p62 subunit of TFIIH.
    Chabot PR; Raiola L; Lussier-Price M; Morse T; Arseneault G; Archambault J; Omichinski JG
    PLoS Pathog; 2014 Mar; 10(3):e1004042. PubMed ID: 24675874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines.
    Ding W; Wang C; Narita Y; Wang H; Leong MML; Huang A; Liao Y; Liu X; Okuno Y; Kimura H; Gewurz B; Teng M; Jin S; Sato Y; Zhao B
    J Virol; 2022 Sep; 96(18):e0073922. PubMed ID: 36094314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
    Wang L; Grossman SR; Kieff E
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):430-5. PubMed ID: 10618435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of B cell receptor signalling by Epstein-Barr virus nuclear antigens.
    Khasnis S; Veenstra H; McClellan MJ; Ojeniyi O; Wood CD; West MJ
    Biochem J; 2022 Dec; 479(23):2395-2417. PubMed ID: 36383217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
    Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
    Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.
    Masternak K; Muhlethaler-Mottet A; Villard J; Zufferey M; Steimle V; Reith W
    Genes Dev; 2000 May; 14(9):1156-66. PubMed ID: 10809673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.
    Kohlhof H; Hampel F; Hoffmann R; Burtscher H; Weidle UH; Hölzel M; Eick D; Zimber-Strobl U; Strobl LJ
    Blood; 2009 May; 113(22):5506-15. PubMed ID: 19339697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
    Pegman PM; Smith SM; D'Souza BN; Loughran ST; Maier S; Kempkes B; Cahill PA; Simmons MJ; Gélinas C; Walls D
    J Virol; 2006 Aug; 80(16):8133-44. PubMed ID: 16873269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Puglielli MT; Woisetschlaeger M; Speck SH
    J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.
    McClellan MJ; Wood CD; Ojeniyi O; Cooper TJ; Kanhere A; Arvey A; Webb HM; Palermo RD; Harth-Hertle ML; Kempkes B; Jenner RG; West MJ
    PLoS Pathog; 2013 Sep; 9(9):e1003636. PubMed ID: 24068937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.
    Szymula A; Palermo RD; Bayoumy A; Groves IJ; Ba Abdullah M; Holder B; White RE
    PLoS Pathog; 2018 Feb; 14(2):e1006890. PubMed ID: 29462212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.
    Cotter MA; Robertson ES
    Mol Cell Biol; 2000 Aug; 20(15):5722-35. PubMed ID: 10891508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs.
    Wood CD; Veenstra H; Khasnis S; Gunnell A; Webb HM; Shannon-Lowe C; Andrews S; Osborne CS; West MJ
    Elife; 2016 Aug; 5():. PubMed ID: 27490482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.